Christopher D. Alafi, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 94,650 shares at $40.12 ($3.8M) on 2021-05-28, disclosed to the SEC on 2021-05-28.
Open-market sale of $3.8M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.01 | 8,482 | $339K | 8.9% |
| 2 | $40.01 | 8,482 | $339K | 8.9% |
| 3 | $40.12 | 38,843 | $1.6M | 41.1% |
| 4 | $40.12 | 38,843 | $1.6M | 41.1% |
| Total | $40.10 avg | 94,650 | $3.8M | 100% |
| Filing → |
| ITCI | BUY | 2020-09-11 | $590K | — | Filing → |
| ITCI | BUY | 2019-09-11 | $9.8M | — | Filing → |
| ITCI | BUY | 2019-09-04 | $1.1M | — | Filing → |